Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities
Navin Suthahar, Wouter C. Meijers, Herman H.W. Silljé, et al.
Current Heart Failure Reports (2017) Vol. 14, Iss. 4, pp. 235-250
Open Access | Times Cited: 264

Showing 1-25 of 264 citing articles:

COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
Raul D. Mitrani, Nitika Dabas, Jeffrey J. Goldberger
Heart Rhythm (2020) Vol. 17, Iss. 11, pp. 1984-1990
Open Access | Times Cited: 304
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
Rudolf A. de Boer, Gilles W. De Keulenaer, Johann Bauersachs, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 3, pp. 272-285
Open Access | Times Cited: 240
Hyaluronic Acid: A Key Ingredient in the Therapy of Inflammation
Andreia Marinho, Cláudia Nunes, Salette Reis
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1518-1518
Open Access | Times Cited: 231
Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
Sara Panizo, Laura Martínez‐Arias, Cristina Alonso‐Montes, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 408-408
Open Access | Times Cited: 225
The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Leandro Moretti, Jack Stalfort, Thomas H. Barker, et al.
Journal of Biological Chemistry (2021) Vol. 298, Iss. 2, pp. 101530-101530
Open Access | Times Cited: 217
Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Houman Savoji, Mohammad Hossein Mohammadi, Naimeh Rafatian, et al.
Biomaterials (2018) Vol. 198, pp. 3-26
Open Access | Times Cited: 191
Galectin-3 in Cardiovascular Diseases
Valeria Blanda, Umberto Marcello Bracale, Maria Donata Di Taranto, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9232-9232
Open Access | Times Cited: 159
Galectin-3 in Heart Failure
Carolin Gehlken, Navin Suthahar, Wouter C. Meijers, et al.
Heart Failure Clinics (2017) Vol. 14, Iss. 1, pp. 75-92
Open Access | Times Cited: 110
Sweet, yet underappreciated: Proteoglycans and extracellular matrix remodeling in heart disease
Geir Christensen, Kate M. Herum, Ida G. Lunde
Matrix Biology (2018) Vol. 75-76, pp. 286-299
Closed Access | Times Cited: 84
Sex‐related differences in contemporary biomarkers for heart failure: a review
Navin Suthahar, Laura M.G. Meems, Jennifer E. Ho, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 5, pp. 775-788
Open Access | Times Cited: 83
Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension
Daniel N. Meijles, Joshua J. Cull, Thomais Markou, et al.
Hypertension (2020) Vol. 76, Iss. 4, pp. 1208-1218
Open Access | Times Cited: 78
Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis
Anita A. Pinar, Tara Scott, Brooke M. Huuskes, et al.
Pharmacology & Therapeutics (2020) Vol. 209, pp. 107511-107511
Closed Access | Times Cited: 77
The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
Grażyna Sygitowicz, Agata Maciejak, Dariusz Sitkiewicz
Biomolecules (2021) Vol. 12, Iss. 1, pp. 46-46
Open Access | Times Cited: 65
Heart regeneration: 20 years of progress and renewed optimism
Jessica C. Garbern, Richard Lee
Developmental Cell (2022) Vol. 57, Iss. 4, pp. 424-439
Open Access | Times Cited: 58
The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy
Anne G. Raafs, Job A.J. Verdonschot, Michiel T.H.M. Henkens, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 6, pp. 933-944
Open Access | Times Cited: 57
Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences
Andreas Goette, Uwe Lendeckel
Cells (2021) Vol. 10, Iss. 10, pp. 2605-2605
Open Access | Times Cited: 57
Cardiac damage in autoimmune diseases: Target organ involvement that cannot be ignored
Shu-Yue Pan, Huimin Tian, Yong‐Guan Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Galectin-3 is involved in inflammation and fibrosis in arteriogenic erectile dysfunction via the TLR4/MyD88/NF-κB pathway
Guanbo Wang, Ruiyu Li, Feng Chen, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Inflammation unites diverse acute and chronic diseases
Peter Libby, Robin D. Smith, Eric J. Rubin, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Closed Access | Times Cited: 8
Genetic deficiency or pharmacological inhibition of cGAS–STING signalling suppresses kidney inflammation and fibrosis
Baihai Jiao, Changlong An, Hao Du, et al.
British Journal of Pharmacology (2025)
Closed Access | Times Cited: 1
Mechanisms of cardiac collagen deposition in experimental models and human disease
Randy T. Cowling, Daniel Kupsky, Andrew M. Kahn, et al.
Translational research (2019) Vol. 209, pp. 138-155
Open Access | Times Cited: 73
Beta-caryophyllene protects against diet-induced dyslipidemia and vascular inflammation in rats: Involvement of CB2 and PPAR-γ receptors
Dareen A. Youssef, Hassan M. El‐Fayoumi, Mona F. Mahmoud
Chemico-Biological Interactions (2018) Vol. 297, pp. 16-24
Closed Access | Times Cited: 72
Galectin-3: A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology
Akira Hara, Masayuki Niwa, Tomohiro Kanayama, et al.
Biomolecules (2020) Vol. 10, Iss. 9, pp. 1277-1277
Open Access | Times Cited: 66
A molecular basis for the anti‐inflammatory and anti‐fibrosis properties of cannabidiol
Falone Sunda, Afolake Arowolo
The FASEB Journal (2020) Vol. 34, Iss. 11, pp. 14083-14092
Closed Access | Times Cited: 63
Activation of toll like receptor 4 (TLR4) promotes cardiomyocyte apoptosis through SIRT2 dependent p53 deacetylation
Parmeshwar B. Katare, Hina Lateef Nizami, Paramesha Bugga, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top